6 results
10-K
2021 FY
VERV
Verve Therapeutics Inc
14 Mar 22
Annual report
7:04am
this LDLR recycling process. Specifically, PCSK9 protein in the blood binds to LDLR and targets LDLR for destruction. In doing so, PCSK9 reduces
424B4
VERV
Verve Therapeutics Inc
17 Jun 21
Prospectus supplement with pricing info
4:50pm
interrupts this LDLR recycling process. Specifically, PCSK9 protein in the blood binds to LDLR and targets
LDLR for destruction. In doing so, PCSK9
S-1/A
VERV
Verve Therapeutics Inc
14 Jun 21
IPO registration (amended)
6:15am
is then recycled back to the surface of the cell, enabling the process of LDL uptake to recur. PCSK9 protein in the blood interrupts this LDLR recycling process
S-1
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
interrupts this LDLR recycling process. Specifically, PCSK9 protein in the blood binds to LDLR and targets
LDLR for destruction. In doing so, PCSK9
DRS
kgaecox7 k5
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next